135 related articles for article (PubMed ID: 20592617)
1. Short-term risk of HIV disease progression and death in Ugandan children not eligible for antiretroviral therapy.
Charlebois ED; Ruel TD; Gasasira AF; Achan J; Kateera F; Akello C; Cao H; Dorsey G; Rosenthal PJ; Ssewanyana I; Kamya MR; Havlir DV
J Acquir Immune Defic Syndr; 2010 Nov; 55(3):330-5. PubMed ID: 20592617
[TBL] [Abstract][Full Text] [Related]
2. Determinants of clinical progression in antiretroviral-naive HIV-infected patients starting highly active antiretroviral therapy. Aquitaine Cohort, France, 1996-2002.
Bonnet F; Thiébaut R; Chêne G; Neau D; Pellegrin JL; Mercié P; Beylot J; Dabis F; Salamon R; Morlat P;
HIV Med; 2005 May; 6(3):198-205. PubMed ID: 15876287
[TBL] [Abstract][Full Text] [Related]
3. Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.
Oliveira R; Krauss M; Essama-Bibi S; Hofer C; Robert Harris D; Tiraboschi A; de Souza R; Marques H; Succi R; Abreu T; Della Negra M; Hazra R; Mofenson LM; Siberry GK;
Clin Infect Dis; 2010 Dec; 51(11):1325-33. PubMed ID: 21039218
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of surrogate markers and clinical outcomes in two-year follow-up of eighty-six human immunodeficiency virus-infected pediatric patients.
Valentine ME; Jackson CR; Vavro C; Wilfert CM; McClernon D; St Clair M; Katz SL; McKinney RE
Pediatr Infect Dis J; 1998 Jan; 17(1):18-23. PubMed ID: 9469389
[TBL] [Abstract][Full Text] [Related]
5. Factors Associated with Timing of Initiation of Antiretroviral Therapy among HIV-1 Infected Adults in the Niger Delta Region of Nigeria.
Ogoina D; Finomo F; Harry T; Inatimi O; Ebuenyi I; Tariladei WW; Afolayan AA
PLoS One; 2015; 10(5):e0125665. PubMed ID: 25933356
[TBL] [Abstract][Full Text] [Related]
6. Dynamics of T cell activation accompanying CD4 recovery in antiretroviral treated HIV-infected Ugandan children.
Ruel T; Ssewanyana I; Achan J; Gasasira A; Kamya MR; Kekitiinwa A; Wong JK; Cao H; Havlir D; Charlebois ED
Clin Immunol; 2009 Jun; 131(3):410-4. PubMed ID: 19303366
[TBL] [Abstract][Full Text] [Related]
7. Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.
Kourtis AP; Wiener J; King CC; Heffron R; Mugo NR; Nanda K; Pyra M; Donnell D; Celum C; Lingappa JR; Baeten JM;
J Acquir Immune Defic Syndr; 2017 Jan; 74(1):38-43. PubMed ID: 27787340
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of virological and immunological responses after 6 months of antiretroviral treatment in adults with HIV-1 infection in sub-Saharan Africa.
De Luca A; Marazzi MC; Mancinelli S; Ceffa S; Altan AM; Buonomo E; Prosperi MC; Pedruzzi B; Noorjehan AM; Scarcella P; Liotta G; Palombi L
J Acquir Immune Defic Syndr; 2012 Mar; 59(3):236-44. PubMed ID: 22327246
[TBL] [Abstract][Full Text] [Related]
9. Virologic suppression in nevirapine-exposed HIV-infected infants initiating antiretroviral therapy in rural Uganda.
Kay J; Wanzira H; Sandison T; Kakuru A; Bigira V; Kamya M; Homsy J; Tappero JW; Havlir D; Dorsey G; Ruel T
J Trop Pediatr; 2012 Jun; 58(3):194-9. PubMed ID: 21930666
[TBL] [Abstract][Full Text] [Related]
10. Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts.
Munderi P; Walker AS; Kityo C; Babiker AG; Ssali F; Reid A; Darbyshire JH; Grosskurth H; Mugyenyi P; Gibb DM; Gilks CF;
HIV Med; 2010 May; 11(5):334-44. PubMed ID: 20136661
[TBL] [Abstract][Full Text] [Related]
11. Successful paediatric HIV treatment in rural primary care in Africa.
Janssen N; Ndirangu J; Newell ML; Bland RM
Arch Dis Child; 2010 Jun; 95(6):414-21. PubMed ID: 19880392
[TBL] [Abstract][Full Text] [Related]
12. Atorvastatin reduces T-cell activation and exhaustion among HIV-infected cART-treated suboptimal immune responders in Uganda: a randomised crossover placebo-controlled trial.
Nakanjako D; Ssinabulya I; Nabatanzi R; Bayigga L; Kiragga A; Joloba M; Kaleebu P; Kambugu AD; Kamya MR; Sekaly R; Elliott A; Mayanja-Kizza H
Trop Med Int Health; 2015 Mar; 20(3):380-90. PubMed ID: 25441397
[TBL] [Abstract][Full Text] [Related]
13. Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children.
Palumbo PE; Raskino C; Fiscus S; Pahwa S; Fowler MG; Spector SA; Englund JA; Baker CJ
JAMA; 1998 Mar; 279(10):756-61. PubMed ID: 9508151
[TBL] [Abstract][Full Text] [Related]
14. Predictors of mortality in HIV-1 infected children on antiretroviral therapy in Kenya: a prospective cohort.
Wamalwa DC; Obimbo EM; Farquhar C; Richardson BA; Mbori-Ngacha DA; Inwani I; Benki-Nugent S; John-Stewart G
BMC Pediatr; 2010 May; 10():33. PubMed ID: 20482796
[TBL] [Abstract][Full Text] [Related]
15. HIV-1 viral load and CD4 cell count in untreated children with vertically acquired asymptomatic or mild disease. Paediatric European Network for Treatment of AIDS (PENTA).
AIDS; 1998 Mar; 12(4):F1-8. PubMed ID: 9520161
[TBL] [Abstract][Full Text] [Related]
16. Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy.
Flynn AG; Anguzu G; Mubiru F; Kiragga AN; Kamya M; Meya DB; Boulware DR; Kambugu A; Castelnuovo BC
PLoS One; 2017; 12(12):e0189055. PubMed ID: 29244807
[TBL] [Abstract][Full Text] [Related]
17. Mortality and its predictors among antiretroviral therapy naïve HIV-infected individuals with CD4 cell count ≥350 cells/mm(3) compared to the general population: data from a population-based prospective HIV cohort in Uganda.
Masiira B; Baisley K; Mayanja BN; Kazooba P; Maher D; Kaleebu P
Glob Health Action; 2014; 7():21843. PubMed ID: 24433941
[TBL] [Abstract][Full Text] [Related]
18. Effect of antiretroviral therapy on viral load, CD4 cell count, and progression to acquired immunodeficiency syndrome in a community human immunodeficiency virus-infected cohort. Swiss HIV Cohort Study.
Erb P; Battegay M; Zimmerli W; Rickenbach M; Egger M
Arch Intern Med; 2000 Apr; 160(8):1134-40. PubMed ID: 10789606
[TBL] [Abstract][Full Text] [Related]
19. Severe mental illness at ART initiation is associated with worse retention in care among HIV-infected Ugandan adults.
Nachega JB; Mutamba B; Basangwa D; Nguyen H; Dowdy DW; Mills EJ; Katabira E; Nakimuli-Mpungu E
Trop Med Int Health; 2013 Jan; 18(1):53-7. PubMed ID: 23136882
[TBL] [Abstract][Full Text] [Related]
20. Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
Srasuebkul P; Ungsedhapand C; Ruxrungtham K; Boyd MA; Phanuphak P; Cooper DA; Law MG
HIV Med; 2007 Jan; 8(1):46-54. PubMed ID: 17305932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
